
POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
Author(s) -
C Muhas,
K. M. Nishad,
K P Ummunnoora,
K Jushna,
K V Saheera,
K P Dilsha
Publication year - 2018
Publication title -
international journal of current pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 0975-7066
DOI - 10.22159/ijcpr.2018v10i6.30969
Subject(s) - polycystic ovary , hyperandrogenism , insulin resistance , etiology , infertility , medicine , endocrine system , anovulation , menstrual cycle , hirsutism , population , androgen excess , menstruation , gynecology , diabetes mellitus , endocrinology , hormone , biology , pregnancy , environmental health , genetics
Polycystic ovary syndrome (PCOS) is one of most common female endocrine disorder that affects 6-15% of the female population. Women with PCOS have a hormonal imbalance and metabolism problems that may affect their overall health and appearance. Androgen excess and insulin resistance are currently recognized to be responsible for much of the phenotypic presentation, though insulin resistance is far from universally present. It is characterized by irregular menstrual cycle, acne and also associated with type-2 diabetes mellitus and cardiovascular disease. Efficient management of PCOS provides a prospective window of opportunity to avoid the risk of associated complications. Treatment is broadly aimed at tackling (IR), effects of hyperandrogenism, irregular menstruation, and infertility. This review article mainly deals with the etiology, pathophysiology, diagnosis and management of Polycystic ovary syndrome.